Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
AZOO Undisclosed Series ARege Nephro Co $10.6M Series CRanked by rounds participated in, from announcements in Jul 21, 2026 – Oct 18, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
AZOO Undisclosed Series ARege Nephro Co $10.6M Series CNew companies 2 · Follow-on 0
Stages: Series A 2
AZOO Undisclosed Series ABridgeSmile Co., Ltd. ¥819M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
Foundry ₹120M Pre-seedProtein Pantry ₹90M SeedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Salience Labs $125M Series BFasset $68M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Augur Undisclosed Strategic investmentOlix $312M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Soufflé Therapeutics $135M Series BNetwork Bio $50M StrategicNew companies 2 · Follow-on 0
Stages: Series A 2
Clueso $10M Series AMesa School of Business ₹1.1B Series A and venture debtNew companies 2 · Follow-on 0
Stages: Undisclosed 2
MakeO ₹900M UndisclosedTriangle Group $15M Seed+DebtNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
reebuild €3M Seed3Folio Undisclosed InvestmentNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Mesa School of Business ₹1.1B Series A and venture debtRiver Mobility $120M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Undecimal Bio $18M SeedMindgard $30M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Soufflé Therapeutics $135M Series BRobigo Undisclosed Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Quick Undisclosed Capital and business alliance agreementmutex ¥281.6M Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Soufflé Therapeutics $135M Series BFaro AI $37.3M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
CarbonFarm €7M Series AARC Ride $33.3M FundingNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Soufflé Therapeutics $135M Series BQuintessent $40M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Undecimal Bio $18M SeedShennon Biotechnologies $12M FundingNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
CarbonFarm €7M Series ACubicup €2M Funding roundNew companies 2 · Follow-on 0
Stages: Undisclosed 2
ID Finance €545M Debt and equity financingCashea $100M Series A+Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
Suki $90M Series EEncoded Therapeutics Inc. $275M Series FNew companies 2 · Follow-on 0
Stages: Series B 2
Soufflé Therapeutics $135M Series BInduPro $77M Series BNew companies 2 · Follow-on 0
Stages: Undisclosed 2
ID Finance €545M Debt and equity financingCashea $100M Series A+Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
HyLight €13M Funding roundSilicon Data $30.5M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
HyLight €13M Funding roundStrong by Form $6.6M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.